10.1523/JNEUROSCI.0430-10.2010 279 TatemotoK.CarlquistM.MuttV
Description Ingredients: Purified water, butylene glycol, beeswax, caprylic/capric triglyceride, niacinamide, cetearyl alcohol, isononyl isononanoate, arachidyl alcohol, 1,2-hexanediol, polyglyceryl-3 methylglucose distearate, behenyl alcohol, glyceryl stearate, betaine, arachidyl glucoside, allantoin, sorbitan oleate, panthenol, hydrogenated lecithin, tocopherol, xanthan gum, glycerin, Glutathione (600 ppm), ethylhexylglycerin, dipotassium glycyrrhizate, stearic acid, disodium EDTA, bisabolol, sodium hyaluronate, ascorbyl tetraisopalmitate, glucose, balm leaf extract, ladys mantle extract, yarrow extract, speedwell extract, peppermint leaf extract, evening primrose extract, polyglyceryl-10 stearate, ceramide NP, sodium ascorbyl phosphate, ceramide NS, cholesterol, phytosphingosine, ceramide AP, ceramide AS, sodium hydroxide, biotin, acetyl hexapeptide-8, copper tripeptide-1, pyridoxine, oligopeptide-29, oligopeptide-32, cyanocobalamine, palmitoyl pentapeptide-4, ceramide EP, riboflavin, beta-carotene, thiamine HCL, fragrance.
No, not an MBA, which is a business degree and would be strange for a medication to have, but N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)
it can increase the risk of diabetic ketoacidosis (DKA)
Following NICE approval, Mounjaro is being rolled out through specialist weight management services, but eligibility criteria are strict, typically requiring a BMI of 40+ (or 37.5+ for certain ethnic backgrounds) with multiple weight-related health conditions
Patients lost up to 22.7% of their body weight over 68 weeks, compared to 22.5% on Mounjaro over 72 weeks
